Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial-Reference-Cited by-同舟云学术

Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial

Published:2003-01 Issue:9353 Volume:361 Page:201-205
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Friederich Philip W,Henny Christiaan P,Messelink Embert J,Geerdink Mark G,Keller Tymen,Kurth Karl-Heinz,Büller Harry R,Levi Marcel

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Early complications of contemporary anatomical radical retropubic prostatectomy;Andriole;J Urol,1994

2. A randomized trial of perioperative hemodilution versus transfusion of preoperatively deposited autologous blood in elective surgery;Ness;Transfusion,1992

3. Intraoperative blood loss and prognosis in prostate cancer patients undergoing radical retropubic prostatectomy;Oefelein;J Urol,1995

4. Radical retropubic prostatectomy outcomes at a community hospital;Gaylis;J Urol,1998

5. Autologous blood donation prior to anatomical radical retropubic prostatectomy: is it necessary?;Goh;Urology,1997

Cited by 377 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale for the Potential Use of Recombinant Activated Factor VII in Severe Post-Partum Hemorrhage;Journal of Clinical Medicine;2024-05-16

2. Congenital Factor VII Deficiency, Diagnosis, and Management;Congenital Bleeding Disorders;2023

3. Role of Recombinant Activated Factor VIIa (rFVIIa) in Bleeding Mycotic Aneurysm of the Abdominal Aorta;Journal of the College of Physicians and Surgeons Pakistan;2022-09-01

4. Use of recombinant activated factor VII for the treatment of perioperative bleeding in noncardiac surgery patients without hemophilia: A systematic review and meta-analysis of randomized controlled trials;Journal of Critical Care;2021-04

5. Use of Low-Dose Recombinant Factor Ⅶa for Uncontrolled Perioperative Bleeding;Dose-Response;2020-10-01